Nexentis Techgnologies Inc (NXTS)

Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS)June 29, 2026 10:10 AM
IH Market News Nexentis Technologies Inc. (NASDAQ:NXTS) shares advanced 10% on Monday after the company announced the partial monetisation of its investment in the Melz solar project in Germany, based on a project valuation of US$14.5 million. The drug discovery company, which also maintains investments in renewable energy assets, has signed an addendum to its Loan and Partnership Agreement with Solterra Renewable Energy Ltd. and the project’s lending group. The revised agreement values the Melz solar photovoltaic development at US$14.5 million, representing an uplift from Nexentis’ original investment. Transaction Unlocks Early Returns As part of the agreement, Nexentis will receive an early repayment of approximately US$147,000, including accrued interest, on its share of the project loan. The company will also receive US$98,000 from the sale of 10% of its profit rights, equivalent to a 2.5% interest in the project’s future profits. In addition, Nexentis will collect a further US$22,000 as an option fee granting the purchaser the right to acquire its remaining profit rights once the project reaches Ready-to-Build (RTB) status, based on an independent valuation carried out by a Big Four accounting firm. Melz Project Continues Development The updated agreement follows the sale of Solterra Renewable Energy Ltd. and its assets to Sunflower Sustainable Investments Ltd., a transaction that prompted Solterra to make early partial repayments under the existing loan arrangements. The lending syndicate, in which Nexentis is the largest participant, committed approximately US$2.95 million to support the development of the Melz project through to RTB status. Nexentis’ share of that funding totals around US$2.18 million. The Melz solar project, which is expected to have a generation capacity of between 111 MWp and 115 MWp, continues to progress through the development phase. The latest transaction implies a valuation of approximately US$120,000 per megawatt. Nexentis Technologies stock priceThe post Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS) appeared first on US Editors. Original: Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS)

Lol. NXTS Ran to $23+, closed at $13+ before the company ruined the run with an idiotic offering. Based on the very easy movement during the run, I thought $89 would be possible afterhours if the momemtum continues.

$NXTS: Good to know you're watching for $89


Watch for $6 first though !

Time is MONEY

GO $NXTS

NXTS..............................................https://stockcharts.com/sc3/ui/?s=NXTS&p=w&b=5&g=0&id=p86431144783

Renewable energy plus AI molecular drug discovery! Interesting...

Watching NXTS for $89

NXTS...$18.13...🥳...Another early alert at $5.80...

georgie18

Re: georgie18 post# 93

Monday, June 22, 2026 9:33:33 AM

Post#
94
of 95
NXTS...$13.12...🥳...Off my $5.80 Alert...

georgie18

Re: georgie18 post# 91

Monday, June 22, 2026 9:18:55 AM

Post#
93
of 93
NXTS...$11.15...🥳...Off my $5.80 Alert...

georgie18

Re: None

Tuesday, June 16, 2026 7:10:04 AM

Post#
91
of 92
NXTS...$5.80...🥳...Pre Market Volume...

NXTS Holy Crap Great Call. Hopefully VSST Goes Too. NXTS Just Merged Their Subsidiary Save Foods Into VSST And Now Own 90% Of VSST

NXTS...$13.12...🥳...Off my $5.80 Alert...

georgie18

Re: georgie18 post# 91

Monday, June 22, 2026 9:18:55 AM

Post#
93
of 93
NXTS...$11.15...🥳...Off my $5.80 Alert...

georgie18

Re: None

Tuesday, June 16, 2026 7:10:04 AM

Post#
91
of 92
NXTS...$5.80...🥳...Pre Market Volume...

NXTS...$11.15...🥳...Off my $5.80 Alert...

georgie18

Re: None

Tuesday, June 16, 2026 7:10:04 AM

Post#
91
of 92
NXTS...$5.80...🥳...Pre Market Volume...

Nexentis Shares Swing After Subsidiary Reaches Drug Discovery Research MilestoneJune 17, 2026 9:00 AM
IH Market News Nexentis Technologies Inc. (NASDAQ:NXTS) experienced sharp trading volatility on Wednesday after announcing a research breakthrough at its biotechnology subsidiary, MitoCareX Bio. The stock initially surged as much as 30% following the news before reversing course and trading about 2% lower later in the session. MitoCareX Expands Analysis of SLC Transport Proteins The company said MitoCareX has completed a broad structural assessment of human Solute Carrier (SLC) transport proteins, a project designed to strengthen its small-molecule drug discovery platform. The research builds on MITOLINE, the subsidiary’s proprietary sequence analysis and alignment technology, which has previously been used to prepare mitochondrial SLC25 carrier proteins for three-dimensional modeling applications targeting difficult-to-treat cancers and inflammatory metabolic disorders. Findings Could Broaden Drug Discovery Opportunities According to the company, the analysis identified additional SLC proteins outside the SLC25 family whose amino acid structures appear compatible with the MITOLINE framework. As a result, MitoCareX plans to investigate whether MITOLINE-generated 3D models can be incorporated into virtual screening programmes focused on selected non-mitochondrial SLC targets. Management believes this approach could extend the platform’s applicability to a wider range of disease-relevant transport proteins and potentially unlock new therapeutic opportunities. Computational Platform Remains Central to Strategy The subsidiary aims to expand the number of clinically significant transporters it can address while maintaining a computationally driven discovery process. By leveraging advanced modeling and screening techniques, MitoCareX is seeking to accelerate the identification of promising small-molecule candidates without relying solely on traditional laboratory-intensive methods. The company views this strategy as an efficient way to broaden its drug development pipeline. Management Highlights Recent Progress David Palach, Chief Executive Officer of Nexentis, said the latest achievement follows recent advances made by MitoCareX, including the announcement of an optimized hit molecule. He noted that the new findings demonstrate both the flexibility and potential of the MITOLINE platform, as well as the company’s ability to identify additional transporter targets that may benefit from MITOLINE-enabled 3D modeling. Diversified Business Model Nexentis operates as a drug discovery company focused on developing novel therapeutic candidates through its biotechnology activities. In addition to its life sciences operations, the company also invests in solar energy projects using a Ready-to-Build (RTB) development model, providing exposure to both healthcare innovation and renewable energy infrastructure. The latest update highlights continued efforts to expand the scientific reach of its drug discovery platform while advancing new opportunities for future research and development. Nexentis Technologies stock priceThe post Nexentis Shares Swing After Subsidiary Reaches Drug Discovery Research Milestone appeared first on US Editors. Original: Nexentis Shares Swing After Subsidiary Reaches Drug Discovery Research Milestone

NXTS...$5.80...🥳...Pre Market Volume...

NITO..........................................................p/m

Neato run up to $3

About N2OFF Inc:

N2OFF owns 100% of MitoCareX Bio Ltd, a drug delivery company engaged in drug discovery targeting cancer therapeutics and other diseases through the mitochondrial SLC25 protein family. Additionally, N2OFF adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build ) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd

N2OFF also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.

Average volume is under 50k. Today over 1.5 million.

$NITO: WTF......... boosting now to $7


Wasssupppppppppppppppppppppppppppppppppppppppppp


Up $3/sh on the day so far.


GO $NITO

Bashing just selling a pump quickly and cashing out $$$ it stopped at 10.68 resistance. If you want to risk stay until 11.74 or 12.62 chances of reward get much higher and improbable. Would rather tell you to do a short at Tradezero sooner if 10.80 not broken. The pumpers are also working the short side of trade. None of this financial advice just for educational purposes. 

why are you bashing it? this …

..

is not like you.

$11.08 get out sell sell don't look back a gain is a gain

$9.23 sell the merger news

in on merger news. lets do this!

Near blow some NITO &7.87

Volume up 15 times first thing this morning.... 

Ahh......so if you don't agree with news/things you see........it's Fake..........got it........lol

And fwiw, God doesn't judge, OR punish.......God is Love.....and the only thing love can do is LOVE.....

Z

Greetings Zardiw..
Too late. We've been onto fake news for some time, not to mention...
🙂 On CBN News & official website (not Google) the video doesn't exist.
God gave everyone a free will. The enemy always tries to force, beat, oppress people into submission.
My last remark (then back to discussion about the stock, after all... This is a STOCK forum.

God Himself showed up to fight the battle. Make no mistake. He's leading them.
You can't fight God. He's God. And a merciful one. Evil is never merciful.
God is crushing it.
Did Babylon succeed. No.
Did Hitler succeed. No.
Did Osama succeed and thrive. No.
Did Fidel Castro. No.
Did the brutal Roman Empire succeed. No.
Knock yourself out.
I end with..
Galatians 1:8-9 states
Anyone, including Paul or an angel, who preaches a different gospel than the one they received is cursed.
Galatians 1:8-9
"But even if we, or an angel from heaven, preach to you a gospel contrary to what we have preached to you, let him be accursed."

Go Google how israel treats your Christian buddies............hint.......spits on them in public:



Z

To Zardiw & your comment:
"...seems to be a pattern with these israeli stocks"
You didn't say,
"seems to be a pattern with these stocks"...
You targeted a specific nation.
Interesting.
This usually denotes hatred & propaganda.
Not only is your statement false, it's laughable because it's false.
You almost appear to possibly enjoy listening to those words spewing out of your heart, into your head and rolling off your lips
Prejudice and hate will NEVER prevail. Especially against that tiny nation. The only God that is truly God always wins.
Because He IS God. Even you know it deep inside but we're probably taught to hate it.
Where are all the false gods now.
Their God did not rescue them because he doesn't have any power, only the power his human followers give him.
Did they die on a cross, tell the truth, know how to love their followers.. come and suffer in place if their followers. Hating God... and following Satan never works and never has, even though you said what you did, God the only true creater who made you still loves you. I pray for you. I dare you to read The Word and it not set you free from all you were taught.
Take your poison... pack up.
Hate and violence always loses in the end.
Always!
Because it is not from the one true God.
He is the Apha and Omega.

Bollinger bands pinching in here, with the money flow readying to hit green territory…https://schrts.co/FhCUEtyz

NITO catching slaps here…

setting uP an inverted hammer 🔨  for today…

movin’ on uP…

.27… setting uP a strong Bullish reversal here…https://schrts.co/MsgkUyeR

hod close, for a daily Bullish Engulfing candle, for the day… 

setting uP a Doji cross reversal…

AdD

.35sss

duplicate prints at .28…

closed gap from 5/2…

 currently an inverted hammer 🔨 … either way, setting uP a reversal daily candle…

setting uP a daily Bullish engulfing candle…

nito trying to make a….

….

come back pre market.

News:
It is extending its international footprint through a new venture in Poland's clean energy sector.

The firm revealed that its unit, Solterra, is contributing financially to a Battery Energy Storage System (BESS) project in Poland.

The first phase of the venture will involve a 35-megawatt system capable of storing 140 megawatt-hours, with intentions to boost its scale considerably in the future.

N2OFF (NITO) is among multiple investors supporting the initial phase of the project through a formalized financing agreement.-

** This could be good.. wait & see.

last shake seems over, going up now.

weeeeeee!!!! lets do this!

here we goooooo!!!!

grabbed some, it ran like hell in the past.

NITO..................................https://stockcharts.com/h-sc/ui?s=NITO&p=W&b=5&g=0&id=p86431144783

Crazy action

DDAmanda lol